Consensus Sotera Health Company

Equities

SHC

US83601L1026

Real-time Estimate Cboe BZX Other stock markets 03:46:02 2024-04-26 pm EDT			5-day change	1st Jan Change
11.34 ^USD	+0.22%		+3.84%	-32.52%

Apr. 04	North American Morning Briefing : Focus Turns to -2-	DJ
Apr. 03	Citigroup Upgrades Sotera Health to Buy From Neutral, Cuts Price Target to $16 From $18	MT

Evolution of the average Target Price on Sotera Health Company

Price target over the last 5 years

History of analyst recommendation changes

8ad46f2f6.qDr9Sy4CRAzldroWO7GqZPmkPpO8lPDt5mlWUXYtdVk.7BeWMxg2El7IN9lmVcjuI5SWX__S4p-dtwAgFh0YMmndAo4Ze1Y1YoIi9w~aa72f396649d0fd216f02e31b6f1e3e2

Analyst Recommendations on Sotera Health Company

Citigroup Upgrades Sotera Health to Buy From Neutral, Cuts Price Target to $16 From $18	Apr. 03	MT
Sotera Health Shares Rise Following Jefferies Upgrade	Mar. 25	MT
Jefferies Upgrades Sotera Health to Buy From Hold, Price Target is $15.50	Mar. 25	MT
Barclays Adjusts Price Target on Sotera Health to $17 From $15, Maintains Overweight Rating	Jan. 25	MT
RBC Cuts Price Target on Sotera Health to $20 From $22, Keeps Outperform Rating	Nov. 02	MT
KeyBanc Adjusts Price Target on Sotera Health to $23 From $24, Maintains Overweight Rating	23-08-04	MT
RBC Raises Price Target on Sotera Health to $22 From $18, Keeps Outperform Rating	23-08-04	MT
Sotera Health Upgraded by KeyBanc to Overweight From Sector Weight Post Settlement of Ethylene Oxide Claims, Price Target Set at $24	23-06-26	MT
Barclays Adjusts Price Target on Sotera Health to $20 From $21, Maintains Overweight Rating	23-05-04	MT
RBC Cuts Price Target on Sotera Health to $18 From $19, Maintains Outperform Rating	23-05-04	MT
Barclays Adjusts Sotera Health Price Target to $21 From $22, Maintains Overweight Rating	23-04-04	MT
RBC Boosts Price Target on Sotera Health to $19 From $8, Maintains Outperform Rating	23-03-01	MT
JPMorgan Upgrades Sotera Health to Neutral From Underweight, Adjusts Price Target to $18 From $6	23-01-23	MT
Barclays Upgrades Sotera Health to Overweight From Underweight, Adjusts Price Target to $22 From $6	23-01-11	MT
Wolfe Research Upgrades Sotera Health to Outperform From Peer Perform, Price Target is $25	23-01-11	MT
Goldman Sachs Adjusts Sotera Health's Price Target to $8 From $9, Keeps Neutral Rating	22-11-23	MT
Barclays Downgrades Sotera Health Company to Underweight From Equalweight, Lowers Price Target to $6 From $7	22-11-15	MT
Barclays Trims Sotera Health Company's Price Target to $7 From $8, Maintains Equalweight Rating	22-11-03	MT
Citigroup Lowers Sotera Health Company's Price Target to $7 From $9, Maintains Neutral Rating	22-11-03	MT
Jefferies Lowers Sotera Health Company's Price Target to $7 From $21, Maintains Hold Rating	22-11-03	MT
JPMorgan Lowers Sotera Health Company's Price Target to $6 From $9, Maintains Underweight Rating	22-11-03	MT
RBC Cuts Price Target on Sotera Health to $8 From $25, Maintains Outperform Rating	22-11-03	MT
Barclays Adjusts Sotera Health's Price Target to $8 From $22, Keeps Equalweight Rating	22-10-06	MT
Citigroup Downgrades Sotera Health to Neutral From Buy; Price Target is $9	22-10-05	MT
Capitulation ahead?	22-09-26